Fanconi's anemia, transplantation, and cancer

Pediatric Transplantation

Volumn 9, Issue SUPPL. 7, 2005, Pages 81-86

  Alter, Blanche P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aplastic anemia; Bone marrow transplant; Cancer; Fanconi's anemia; Leukemia

Indexed keywords

CLINICAL EXAMINATION; CONFERENCE PAPER; FANCONI ANEMIA; HEAD AND NECK CARCINOMA; HUMAN; MORTALITY; RISK ASSESSMENT; SOLID TUMOR; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; FANCONI ANEMIA; FEMALE; GENITAL NEOPLASMS, FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS; RISK; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS;

EID: 28344457833     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00440.x     Document Type: Conference Paper

References (20)

1. ALTER BP. Cancer in Fanconi Anemia, 1927-2001. Cancer 2003: 97: 425-440.
2. KUTLER DI, SINGH B, SATAGOPAN J et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003: 101: 1249-1256.
3. JOENJE H, PATEL KJ. The emerging genetic and molecular basis of Fanconi Anaemia. Nat Rev Genet 2001: 2: 446-459.
4. MEETEI AR, LEVITUS M, XUE Y, et al. X-linked inheritance of Fanconi Anemia complementation group B. Nat Genet 2004: 36: 1219-1224.
5. LEVITUS M, ROOIMANS MA, STELTENPOOL J, et al. Heterogeneity in Fanconi Anemia: evidence for two new genetic subtypes. Blood 2004: 103: 2498-2503.
6. HOWLETT NG, TANIGUCHI T, OLSON S, et al. Biallelic inactivation of BRCA2 in Fanconi Anemia. Science 2002: 297: 606-609.
7. GARCIA-HIGUERA I, TANIGUCHI T, GANESAN S, et al. Interaction of the Fanconi Anemia proteins and BRCA1 in a common pathway. Mol Cell 2001: 7: 249-262.
8. ALTER BP. Inherited bone marrow failure syndromes. In: NATHAN DG, ORKIN SH, LOOK AT, GINSBURG D, eds. Nathan and Oski's Hematology of Infancy and Childhood. 6th edn. Philadelphia, PA: WB Saunders, pp. 280-365.
9. FAIVRE L, GUARDIOLA P, LEWIS C, et al. Association of complementation group and mutation type with clinical outcome in Fanconi Anemia. Blood 2000: 96: 4064-4070.
10. ROSENBERG PS, HUANG Z-G, ALTER BP. Individualized risks of first adverse events in patients with Fanconi Anemia. Blood 2004: 104: 350-355.
11. ROSENBERG PS, GREENE MH, ALTER BP. Cancer incidence in persons with Fanconi Anemia. Blood 2003: 101: 822-826.
12. ROSENBERG PS, SOCIE G, ALTER BP, GLUCKMAN, E. Risk of head and neck squamous cell cancer and death in transplanted and untransplanted patients with Fanconi Anemia. Blood 2005: 105: 67-73.
13. VELAZQUEZ I, ALTER BP. Androgens and liver tumors: Fanconi's Anemia and non-fanconi's conditions. Am J Hematol 2004: 77: 257-267.
14. ALTER BP, CARUSO JP, DRACHTMAN RA, UCHIDA T, ELGHETANY MT. Fanconi's Anemia: myelodysplasia as a predictor of outcome. Ca Genet Cytogenet 2000: 117: 125-131.
15. RIES LAG, EISNER MP, KOSARY CL, et al. SEER Cancer Statistics Review, 1973-1998. National Cancer Institute, Bethesda MD, http://seercancer.gov/csr/ 1975-2002.
16. OWEN J, FROHNMAYER L, FILER, ME Fanconi Anemia: Standards for Clinical Care, 2nd edn. Eugene, OR: Fanconi Anemia Research Fund, Inc., 2005.
17. HERMSEN MAJA, XIE Y, ROOIMANS MA, et al. Cytogenetic characteristics of oral squamous cell carcinomas in Fanconi Anemia. Familial Cancer 2001: 1: 39-43.
18. SOARES MF, MACHUCA TN, FILHO PRB, et al. Early presentation of squamous cell carcinoma after bone marrow transplantation in a boy with Fanconi Anemia. J Bras Patol Med Lab 2004: 40: 1-6.
19. ALTER BP. Radiosensitivity in Fanconi's Anemia patients. Radiother Oncol 2002: 62: 345-347.
20. http://www.marrowfailure.cancer.gov.